{"entity":{"type":"insider","cik":"0001326903","url":"/insider/0001326903","json_url":"/insider/0001326903.json","name":"WHALEHAVEN CAPITAL FUND LTD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":2,"first":"2009-08-14","last":"2011-07-25","span_basis":"filed_date"},"name_variants":[{"name":"WHALEHAVEN CAPITAL FUND LTD","source":"filing","n_filings":2,"first_seen":"2009-08-14","last_seen":"2011-07-25"}],"transactions":[{"id":8954469,"accession":"0001213900-11-003836","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-11-003836","line_url":"/filing/0001213900-11-003836#line-4","is_derivative":false,"issuer_cik":"0000838879","issuer_name":"RADIENT PHARMACEUTICALS Corp","issuer_ticker":"RXPC","issuer_name_source":null,"issuer_url":"/issuer/0000838879","owner_cik":"0001326903","owner_name":"WHALEHAVEN CAPITAL FUND LTD","owner_display_name":"WHALEHAVEN CAPITAL FUND LTD","owner_url":"/insider/0001326903","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233000.0,"shares_display":"233,000","price_per_share":0.084,"price_display":"0.08","price_state":"stated","total_value":19572.0,"total_display":"19,572.00","total_whole":"19,572","shares_owned_after":7475000.0,"shares_owned_after_display":"7,475,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-13","filed_date":"2011-07-25","scope":"insider"},{"id":8954468,"accession":"0001213900-11-003836","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-11-003836","line_url":"/filing/0001213900-11-003836#line-3","is_derivative":false,"issuer_cik":"0000838879","issuer_name":"RADIENT PHARMACEUTICALS Corp","issuer_ticker":"RXPC","issuer_name_source":null,"issuer_url":"/issuer/0000838879","owner_cik":"0001326903","owner_name":"WHALEHAVEN CAPITAL FUND LTD","owner_display_name":"WHALEHAVEN CAPITAL FUND LTD","owner_url":"/insider/0001326903","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":905000.0,"shares_display":"905,000","price_per_share":0.0814,"price_display":"0.08","price_state":"stated","total_value":73667.0,"total_display":"73,667.00","total_whole":"73,667","shares_owned_after":7708000.0,"shares_owned_after_display":"7,708,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-12","filed_date":"2011-07-25","scope":"insider"},{"id":8954467,"accession":"0001213900-11-003836","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-11-003836","line_url":"/filing/0001213900-11-003836#line-2","is_derivative":false,"issuer_cik":"0000838879","issuer_name":"RADIENT PHARMACEUTICALS Corp","issuer_ticker":"RXPC","issuer_name_source":null,"issuer_url":"/issuer/0000838879","owner_cik":"0001326903","owner_name":"WHALEHAVEN CAPITAL FUND LTD","owner_display_name":"WHALEHAVEN CAPITAL FUND LTD","owner_url":"/insider/0001326903","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225000.0,"shares_display":"225,000","price_per_share":0.112,"price_display":"0.11","price_state":"stated","total_value":25200.0,"total_display":"25,200.00","total_whole":"25,200","shares_owned_after":8613000.0,"shares_owned_after_display":"8,613,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-11","filed_date":"2011-07-25","scope":"insider"},{"id":8954466,"accession":"0001213900-11-003836","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-11-003836","line_url":"/filing/0001213900-11-003836#line-1","is_derivative":false,"issuer_cik":"0000838879","issuer_name":"RADIENT PHARMACEUTICALS Corp","issuer_ticker":"RXPC","issuer_name_source":null,"issuer_url":"/issuer/0000838879","owner_cik":"0001326903","owner_name":"WHALEHAVEN CAPITAL FUND LTD","owner_display_name":"WHALEHAVEN CAPITAL FUND LTD","owner_url":"/insider/0001326903","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59000.0,"shares_display":"59,000","price_per_share":0.122,"price_display":"0.12","price_state":"stated","total_value":7198.0,"total_display":"7,198.00","total_whole":"7,198","shares_owned_after":8838000.0,"shares_owned_after_display":"8,838,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-08","filed_date":"2011-07-25","scope":"insider"},{"id":5620918,"accession":"0001144204-09-043249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-09-043249","line_url":"/filing/0001144204-09-043249#line-1","is_derivative":false,"issuer_cik":"0001136424","issuer_name":"CONSPIRACY ENTERTAINMENT HOLDINGS INC","issuer_ticker":"CPYE","issuer_name_source":null,"issuer_url":"/issuer/0001136424","owner_cik":"0001326903","owner_name":"WHALEHAVEN CAPITAL FUND LTD","owner_display_name":"WHALEHAVEN CAPITAL FUND LTD","owner_url":"/insider/0001326903","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42000.0,"shares_display":"42,000","price_per_share":0.038,"price_display":"0.04","price_state":"stated","total_value":1596.0,"total_display":"1,596.00","total_whole":"1,596","shares_owned_after":5814142.0,"shares_owned_after_display":"5,814,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-29","filed_date":"2009-08-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000838879","name":"RADIENT PHARMACEUTICALS Corp","url":"/issuer/0000838879","role":"Other","n_filings":1,"first_seen":"2011-07-25","last_seen":"2011-07-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001136424","name":"CONSPIRACY ENTERTAINMENT HOLDINGS INC","url":"/issuer/0001136424","role":"Ten percent owner","n_filings":1,"first_seen":"2009-08-14","last_seen":"2009-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001326903","retrieved_at":"2026-08-25T19:09:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}